PLAY PODCASTS
The Role of Clotting in Long COVID: Special Series from The Cohen Center for Recovery from Complex Chronic Illnesses at Mount Sinai
Episode 484

The Role of Clotting in Long COVID: Special Series from The Cohen Center for Recovery from Complex Chronic Illnesses at Mount Sinai

Why do patients with long COVID have such a wide array of symptoms affecting so many bodily systems? That bedeviling question is the focus of this episode of Raise the Line featuring Dr. Resia Pretorius, head of the Department of Physiological Sciences at Stellenbosch University in South Africa and a renowned researcher in coagulation. “The underlying concept of what is happening, in our minds, is that long COVID is a widespread vascular endotheliitis, which is driven by the presence of all sorts of inflammatory molecules in circulation,” she tells host Dr. Raven Baxter of the Cohen Center for Recovery from Complex Chronic Illnesses (CoRE). Because endothelial cells line blood vessels that travel to every part of the body, their impairment produces a range of symptoms. Dr. Pretorius and her research colleagues have discovered that “microclots” – abnormal proteins that prevent clots from breaking down – are another ingredient in the long COVID recipe due to their possible role in reducing oxygen flow to the brain and other organs. Because of their unusual structure, microclots are not detected by customary blood tests, leading Dr. Pretorius to add her voice to the chorus of stakeholders calling for the development of new diagnostic tests and additional treatments. “We need a concerted effort for trials. We need FDA approval for the laboratory test that we developed. I’m confident we will get it done, but it will take time, which is sad.” Tune in to learn about the possible causes of microclots, promising research on anticoagulation therapy and why long COVID is not a “checklist” disease, as our special series on post-acute infection syndromes continues. Mentioned in this episode: Mount Sinai Health System (www.mountsinai.org) Steven & Alexandra Cohen Foundation (www.stevenandalex.org)

Raise the Line · Dr. Resia Pretorius, Dr. Raven Baxter

June 12, 202441m 0s

Audio is streamed directly from the publisher (cdn.simplecast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Why do patients with long COVID have such a wide array of symptoms affecting so many bodily systems? That bedeviling question is the focus of this episode of Raise the Line featuring Dr. Resia Pretorius, head of the Department of Physiological Sciences at Stellenbosch University in South Africa and a renowned researcher in coagulation. “The underlying concept of what is happening, in our minds, is that long COVID is a widespread vascular endotheliitis, which is driven by the presence of all sorts of inflammatory molecules in circulation,” she tells host Dr. Raven Baxter of the Cohen Center for Recovery from Complex Chronic Illnesses (CoRE). Because endothelial cells line blood vessels that travel to every part of the body, their impairment produces a range of symptoms. Dr. Pretorius and her research colleagues have discovered that “microclots” – abnormal proteins that prevent clots from breaking down – are another ingredient in the long COVID recipe due to their possible role in reducing oxygen flow to the brain and other organs. Because of their unusual structure, microclots are not detected by customary blood tests, leading Dr. Pretorius to add her voice to the chorus of stakeholders calling for the development of new diagnostic tests and additional treatments. “We need a concerted effort for trials. We need FDA approval for the laboratory test that we developed. I’m confident we will get it done, but it will take time, which is sad.” Tune in to learn about the possible causes of microclots, promising research on anticoagulation therapy and why long COVID is not a “checklist” disease, as our special series on post-acute infection syndromes continues. 

Mentioned in this episode:

Mount Sinai Health System

Steven & Alexandra Cohen Foundation

If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Topics

drug costspharmacy benefit managersdrug developmentcontinuing educationcohen center for recovery from complex chronic illnesses (core)johns hopkins universityomicronamy proaldoctorsmedical degreescoronavirushome caredigital healthhealth insurancewearablesfrontline providersosmosis from elsevierendotheliitiscoagulationpfizerfdagovernment policypsilocybinmedicareraise the linedavid putrinovirusmachine learningeducation innovationpharmaceuticalshospital staysinterviewnursing schoolflatten the curvemichael carreseelsevierpost acute infection syndromeailong covidhealthcare entrepreneursnursing cmenursesprimary carehealthcare capacityhealthcare reformspike proteinbig pharmaastra zenecapaiscovid-19rare disordershealthcare workforceexpertsspace repetitionmedical educationnursing shortagelsdmedicaidlearning sciencegene editingvalue-based careresia pretoriustechnologyflipped classroommedicare advantagenursing educationsolutionsphysician shortageprovider burnoutcdcmicroclottingepidemicosmosisraven baxterstellenbosch universitydelta variantremote monitoringhealthcare systemmark cubanosmosis.orgdecision supportrare diseasesvirus outbreakonline educationallied health professionspublic policycovid19edtechshiv gaglanimdmamodernaphysician assistant educationvivian leechelsea clintonpodcastsnursing degreepsychedelicshospital systemspublic healthdr. ashish jhavaccineseric topolyear of the zebradental educationtestingcenters for disease controlpsychedelic-assisted therapyhealth professionspandemicjohnson & johnsontelehealth